NES
JAZZ icon

New England Securities’s Jazz Pharmaceuticals JAZZ Stock Holding History

New England Securities’s Portfolio JAZZ Stock Details JAZZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q4 		$5K Hold
31
– – ﹤0.01% 1258
2014
Q3 		$5K Hold
31
– – ﹤0.01% 1271
2014
Q2 		$5K Hold
31
– – ﹤0.01% 1313
2014
Q1 		$4K Hold
31
– – ﹤0.01% 1334
2013
Q4 		$4K Hold
31
– – ﹤0.01% 1278
2013
Q3 		$3K Hold
31
– – ﹤0.01% 1313
2013
Q2 		$2K Buy
+31
New +$1.9K ﹤0.01% 1264

Other funds holding JAZZ

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
PI
Putnam Investments Boston, Massachusetts $75.7B AUM 34.45% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
JHIU
Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return
LPC
Lone Pine Capital Greenwich, Connecticut $12.5B AUM 54.4% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
WBC
Westpac Banking Corp Sydney, Australia $1.44B AUM 28.5% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

New England Securities's JAZZ Position: Q4 2014 in Review

New England Securities held its Jazz Pharmaceuticals (JAZZ) position steady in Q4 2014 at 31 shares worth $5K. The position accounts for ﹤0.01% of the portfolio, ranked #1258.

New England Securities first reported a position in JAZZ in Q2 2013 and has held it in 7 quarters since. 357 funds tracked by Wall St. Rank hold JAZZ as of Q4 2014.

  • New England Securities held 31 shares of Jazz Pharmaceuticals worth $5K as of Q4 2014.
  • New England Securities left its Jazz Pharmaceuticals share count unchanged in Q4 2014.
  • Jazz Pharmaceuticals made up ﹤0.01% of New England Securities's portfolio in Q4 2014, its #1258 holding.
  • New England Securities first reported a position in Jazz Pharmaceuticals in Q2 2013 and has held it in 7 quarters since.
  • 357 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q4 2014.

Based on New England Securities's 13F filing for Q4 2014, filed 26 Jan 2015.